U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223008) titled 'Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine' on Oct. 28.
Brief Summary: This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into...